Aid and mismatch repair in antibody diversification

Nature Reviews Immunology

Volumn 2, Issue 8, 2002, Pages 605-614

  Martin, Alberto ^a   Scharff, Matthew D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE DEAMINASE; DNA; DNA POLYMERASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MESSENGER RNA; AICDA (ACTIVATION INDUCED CYTIDINE DEAMINASE); AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE);

ANIMAL CELL; ANTIGEN INDUCED DIVERSIFICATION; B LYMPHOCYTE; BURKITT LYMPHOMA; DNA SEQUENCE; DNA STRAND BREAKAGE; ENHANCER REGION; ENZYME ACTIVATION; ESCHERICHIA COLI; GENE CONVERSION; GENETIC RECOMBINATION; HYPERIMMUNOGLOBULINEMIA M; IMMUNE RESPONSE; IMMUNOGENETICS; IMMUNOGLOBULIN VARIABLE REGION; INFECTION; INTRON; LYMPHOMA CELL; MISMATCH REPAIR; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; XERODERMA PIGMENTOSUM; ANIMAL; ANTIBODY PRODUCTION; BASE MISPAIRING; GENE REARRANGEMENT; GENETICS; HUMAN; IMMUNOGLOBULIN GENE; IMMUNOLOGY;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; BASE PAIR MISMATCH; CYTIDINE DEAMINASE; GENE REARRANGEMENT, B-LYMPHOCYTE; GENES, IMMUNOGLOBULIN; HUMANS;

EID: 0036674618     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri858     Document Type: Review

References (117)

1. Weill, J. C. & Reynaud, C. A. Rearrangement/hypermutation/gene conversion: when, where and why? Immunol. Today 17, 92-97 (1996).
2. Diaz, M., Flajnik, M. F. & Klinman, N. Evolution and the molecular basis of somatic hypermutation of antigen-receptor genes. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356, 67-72 (2001).
3. Lanning, D., Zhu, X., Zhai, S. K. & Knight, K. L. Development of the antibody repertoire in rabbit: gut-associated lymphoid tissue, microbes and selection. Immunol. Rev. 175, 214-228 (2000).
4. Sayegh, C. E., Demaries, S. L., Pike, K. A., Friedman, J. E. & Ratcliffe, M. J. The chicken B-cell receptor complex and its role in avian B-cell development. Immunol. Rev. 175, 187-200 (2000).
5. Rajewsky, K., Forster, I. & Cumano, A., Evolutionary and somatic selection of the antibody repertoire in the mouse. Science 238, 1088-1094 (1987).
6. McKean, D. et al. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc. Natl Acad. Sci. USA 81, 3180-3184 (1984).
7. Sale, J. E. & Neuberger, M. S. TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B-cell line. Immunity 9, 859-869 (1998).
8. Zhang, W. et al. Clonal instability of V-region hypermutation in the Ramos Burkitt's lymphoma cell line. Int. Immunol. 13, 1175-1184 (2001).
9. Golding, G. B., Gearhart, P. J. & Glickman, B. W. Patterns of somatic mutations in immunoglobulin variable genes. Genetics 115, 169-176 (1987).
10. Rogozin, I. B. & Kolchanov, N. A. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. Biochim. Biophys. Acta 1171, 11-18 (1992).
11. Shapiro, G. S., Aviszus, K., Ikle, D. & Wysocki, L. J. Predicting regional mutability in antibody V genes based solely on di- and trinucleotide sequence composition. J. Immunol. 163, 259-268 (1999).
12. Michael, N. et al. Effects of sequence and structure on the hypermutability of immunoglobulin genes. Immunity 16, 123-134 (2002).
13. Lebecque, S. G. & Gearhart, P. J. Boundaries of somatic mutation in rearranged immunoglobulin genes: 5′ boundary is near the promoter, and 3′ boundary is approximately 1 kb from V(D)J gene. J. Exp. Med. 172, 1717-1727 (1990).
14. Rada, C., Yelamos, J., Dean, W. & Milstein, C. The 5′ hypermutation boundary of κ chains is independent of local and neighbouring sequences and related to the distance from the initiation of transcription. Eur. J. Immunol. 27, 3115-3120 (1997).
15. Peters, A. & Storb, U. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 4, 57-65 (1996).
16. Maizels, N. Somatic hypermutation: how many mechanisms diversify V-region sequences? Cell 83, 9-12 (1995).
17. Bachl, J., Carlson, C., Gray-Schopfer, V., Dessing, M. & Olsson, C. Increased transcription levels induce higher mutation rates in a hypermutating cell line. J. Immunol. 166, 5051-5057 (2001).
18. Goyenechea, B. et al. Cells strongly expressing Ig(κ) transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers. EMBO J. 16, 3987-3994 (1997).
19. Tumas-Brundage, K. & Manser, T. The transcriptional promoter regulates hypermutation of the antibody heavy-chain locus. J. Exp. Med. 185, 239-250 (1997).
20. Fukita, Y., Jacobs, H. & Rajewsky, K. Somatic hypermutation in the heavy-chain locus correlates with transcription. Immunity 9, 105-114 (1998).
21. Storb, U. et al. Somatic hypermutation of immunoglobulin genes is linked to transcription. Curr. Top. Microbiol. Immunol. 229, 11-19 (1998).
22. Muschen, M. et al. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal-center reaction. J. Exp. Med. 192, 1833-1840 (2000).
23. Pasqualucci, L. et al. BCL-6 mutations in normal germinal-center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl Acad. Sci. USA 95, 11816-11821 (1998). The first report, together with reference 25, to indicate that the SHM mechanism is not restricted to antibody genes. Curiously, this finding has never been replicated in mice, which indicates that differences in SHM targeting exist between mice and humans.
24. Pasqualucci, L., Neri, A., Baldini, L., Dalla-Favera, R. & Migliazza, A. BCL-6 mutations are associated with immunoglobulin variable heavy-chain mutations in B-cell chronic lymphocytic leukemia. Cancer Res. 60, 5644-5648 (2000).
25. Shen, H. M., Peters, A., Baron, B., Zhu, X. & Storb, U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280, 1750-1752 (1998).
26. Pasqualucci, L. et al. Hypermutation of multiple protooncogenes in B-cell diffuse large-cell lymphomas. Nature 412, 341-346 (2001).
27. Storb, U. et al. Cis-acting sequences that affect somatic hypermutation of Ig genes. Immunol. Rev. 162, 153-160 (1998).
28. Shen, H. M., Michael, N., Kim, N. & Storb, U. The TATA binding protein, c-Myc and survivin genes are not somatically hypermutated, while Ig and BCL6 genes are hypermutated in human memory B cells. Int. Immunol. 12, 1085-1093 (2000).
29. Bachl, J. & Wabl, M. Enhancers of hypermutation. Immunogenetics 45, 59-64 (1996).
30. Betz, A. G. et al. Elements regulating somatic hypermutation of an immunoglobulin κ gene: critical role for the intron enhancer/matrix attachment region. Cell 77, 239-248 (1994).
31. Shen, H. M., Peters, A., Kao, D. & Storb, U. The 3′ Igκ enhancer contains RNA polymerase II promoters: implications for endogenous and transgenic κ gene expression. Int. Immunol. 13, 665-674 (2001).
32. Lin, M. M., Green, N. S., Zhang, W. & Scharff, M. D. The effects of Eμ, ′α (hs 1,2) and 3′κ enhancers on mutation of an Ig-VDJ-Cγ2a immunoglobulin heavy gene in cultured B cells. Int. Immunol. 10, 1121-1129 (1998).
33. Yelamos, J. et al. Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature 376, 225-229 (1995).
34. Kodama, M. et al. The PU.1 and NF-EM5 binding motifs in the Igκ 3′ enhancer are responsible for directing somatic hypermutations to the intrinsic hotspots in the transgenic Vκ gene. Int. Immunol. 13, 1415-1422 (2001).
35. Yoshikawa, K. et al. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296, 2033-2036 (2002).
36. Okazaki Im, I., Kinoshita, K., Muramatsu, M., Yoshikawa, K. & Honjo, T. The AID enzyme induces class-switch recombination in fibroblasts. Nature 416, 340-345 (2002). Using an artificial switch substrate, this report shows that AID is the only lymphocyte-specific factor that is required to induce CSR.
37. Jolly, C. J. & Neuberger, M. S. Somatic hypermutation of immunoglobulin κ transgenes: association of mutability with demethylation. Immunol. Cell. Biol. 79, 18-22 (2001).
38. Honjo, T., Kinoshita, K. & Muramatsu, M. Molecular mechanism of class-switch recombination: linkage with somatic hypermutation. Annu. Rev. Immunol. 20, 165-196 (2002).
39. Kuppers, R. & Dalla-Favera, R. Mechanisms of chromosomal translocations in B-cell lymphomas. Oncogene 20, 5580-5594 (2001).
40. Bross, L. et al. DNA double-strand breaks in immunoglobulin genes undergoing somatic hypermutation. Immunity 13, 589-597 (2000).
41. Lo, A. K., Ching, A. K., Lim, P. L. & Chui, Y. L. Strand breaks in immunoglobulin gene hypermutation. Ann. NY Acad. Sci. 815, 432-435 (1997).
42. Papavasiliou, F. N. & Schatz, D. G. Cell-cycle-regulated DNA double-stranded breaks in somatic hypermutation of immunoglobulin genes. Nature 408, 216-221 (2000).
43. Kong, Q. & Maizels, N. DNA breaks in hypermutating immunoglobulin genes: evidence for a break and repair pathway of somatic mutation. Genetics 158, 369-378 (2001).
44. Chua, K. F., Alt, F. W. & Manis, J. P. The function of AID in somatic mutation and class-switch recombination: upstream or downstream of DNA breaks. J. Exp. Med. 195, F37-F41 (2002).
45. Bross, L., Muramatsu, M., Kinoshita, K., Honjo, T. & Jacobs, H. DNA double-strand breaks: prior to but not sufficient in targeting hypermutation. J. Exp. Med. 195, 1187-1192 (2002),
46. Papavasiliou, F. N. & Schatz, D. G. The activation-induced deaminase functions in a postcleavage step of the somatic hypermutation process. J. Exp. Med. 195, 1193-1198 (2002).
47. Muramatsu, M. et al. Class-switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563 (2000). This report, together with reference 92, shows that mice and humans who lack AID are deficient in both CSR and SHM, which indicates that these two processes are mechanistically linked.
48. Peltomaki, P. & Vasen, H. F. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 113, 1146-1158 (1997).
49. Wei, K., Kucherlapati, R. & Edelmann, W. Mouse models for human DNA mismatch-repair gene defects. Trends Mol. Med. 8, 346-353 (2002).
50. Phung, Q. H. et al. Increased hypermutation at G and C nucleotides in immunoglobulin variable genes from mice deficient in the MSH2 mismatch repair protein. J. Exp. Med. 187, 1745-1751 (1998).
51. Rada, C., Ehrenstein, M. R., Neuberger, M. S. & Milstein, C. Hot-spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity 9, 135-141 (1998).
52. Wiesendanger, M., Kneitz, B., Edelmann, W. & Scharff, M. D. Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern. J. Exp. Med. 191, 579-584 (2000).
53. Reynaud, C. A. et al. Mismatch repair and immunoglobulin gene hypermutation: did we learn something? Immunol. Today 20, 522-527 (1999).
54. Vora, K. A. et al. Severe attenuation of the B-cell immune response in Msh2-deficient mice. J. Exp. Med. 189, 471-482 (1999).
55. Frey, S. et al. Mismatch-repair deficiency interferes with the accumulation of mutations in chronically stimulated B cells and not with the hypermutation process. Immunity 9, 127-134 (1998).
56. Zeng, X. et al. DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nature Immunol. 2, 537-541 (2001). Xeroderma pigmentosum variant patients, who lack DNA polymerase η, mutate mostly G-C base pairs, similar to the mutations that are observed in MMR-deficient mice. Together with reference 64, these results indicate that DNA polymerase η might be responsible for the second phase of SHM that involves A-T base pairs.
57. Masutani, C. et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η. Nature 399, 700-704 (1999).
58. Gearhart, P. J. & Wood, R. D. Emerging links between hypermutation of antibody genes and DNA polymerases. Nature Rev. Immunol. 1, 187-192 (2001).
59. Poltoratsky, V., Goodman, M. F. & Scharff, M. D. Error-prone candidates vie for somatic mutation. J. Exp. Med. 192, F27-F30 (2000).
60. Poltoratsky, V. et al. Expression of error-prone polymerases in BL2 cells activated for Ig somatic hypermutation. Proc. Natl Acad. Sci. USA 98, 7976-7981 (2001).
61. Diaz, M., Verkoczy, L. K., Flajnik, M. F. & Klinman, N. R. Decreased frequency of somatic hypermutation and impaired affinity maturation, but intact germinal-center formation in mice expressing antisense RNA to DNA polymerase ζ. J. Immunol. 167, 327-335 (2001).
62. Zan, H. et al. The translesion DNA polymerase ζ plays a major role in Ig and bcl-6 somatic hypermutation. Immunity 14, 643-653 (2001).
63. Rogozin, I. B., Pavlov, Y. I., Bebenek, K., Matsuda, T. & Kunkel, T. A. Somatic mutation hotspots correlate with DNA polymerase η error spectrum. Nature Immunol. 2, 530-536 (2001).
64. Reynaud, C. A., Bertocci, B., Dahan, A. & Weill, J. C. Formation of the chicken B-cell repertoire: ontogenesis, regulation of Ig gene rearrangement, and diversification by gene conversion. Adv. Immunol. 57, 353-378 (1994).
65. Reynaud, C. A., Anquez, V., Grimal, H. & Weill, J. C. A hyperconversion mechanism generates the chicken light-chain preimmune repertoire. Cell 48, 379-388 (1987).
66. Elliott, B. & Jasin, M. Repair of double-strand breaks by homologous recombination in mismatch repair-defective mammalian cells. Mol. Cell. Biol. 21, 2671-2682 (2001). Using cells that are deficient in MSH2, this paper reveals that gene conversion repairs double-stranded DNA breaks by the formation of heteroduplex DNA structures that are subsequently repaired by the MMR system.
67. Li, J., Read, L. R. & Baker, M. D. The mechanism of mammalian gene replacement is consistent with the formation of long regions of heteroduplex DNA associated with two crossing-over events. Mol. Cell. Biol. 21, 501-510 (2001).
68. Buerstedde, J. M. et al. Light-chain gene conversion continues at high rate in an ALV-induced cell line. EMBO J. 9, 921-927 (1990).
69. -/- mutant of the chicken DT40 cell line. Cell 89, 185-193 (1997).
70. Sale, J. E., Calandrini, D. M., Takata, M., Takeda, S. & Neuberger, M. S. Ablation of XRCC2/3 transforms immunoglobulin V-gene conversion into somatic hypermutation. Nature 412, 921-926 (2001). This report shows that DT40 cells, which normally undergo gene conversion, are activated for SHM when XRCC2 or XRCC3 are deleted, thereby providing further evidence for a mechanistic linkage between SHM and gene conversion.
71. Takata, M. et al. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol. Cell. Biol. 21, 2858-2866 (2001).
72. Harris, R. S., Sale, J. E., Petersen-Mahrt, S. K. & Neuberger, M. S. AID is essential for immunoglobulin V gene conversion in a cultured B-cell line. Curr. Biol. 12, 435-438 (2002).
73. Arakawa, H., Hauschild, J. & Buerstedde, J. M. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science 295, 1301-1306 (2002). The finding that immunoglobulin gene conversion in chicken DT40 B cells requires AID (also shown in reference 72) revealed that maturing B cells require AID for all antibody-diversification processes.
74. Pinaud, E. et al. Localization of the 3′ IgH locus elements that affect long-distance regulation of class-switch recombination. Immunity 15, 187-199 (2001).
75. Lee, C. G. et al. Quantitative regulation of class-switch recombination by switch-region transcription. J. Exp. Med. 194, 365-374 (2001).
76. Hein, K. et al. Processing of switch transcripts is required for targeting of antibody class-switch recombination. J. Exp. Med. 188, 2369-2374 (1998).
77. Petersen, S. et al. AID is required to initiate Nbs1/γ-H2AX focus formation and mutations at sites of class switching. Nature 414, 660-665 (2001). The formation of NBS1- and γ-H2AX-containing foci at immunoglobulin switch sites, which is indicative of double-stranded DNA breaks, is absent in AID-deficient B cells. This indicates that AID functions upstream of break induction in CSR.
78. Chen, X., Kinoshita, K. & Honjo, T. Variable deletion and duplication at recombination junction ends: implication for staggered double-strand cleavage in class-switch recombination. Proc. Natl Acad. Sci. USA 98, 13860-13865 (2001).
79. Dunnick, W., Wilson, M. & Stavnezer J. Mutations, duplication and deletion of recombined switch regions indicate a role for DNA replication in the immunoglobulin heavy-chain switch. Mol. Cell. Biol. 9, 1850-1856 (1989).
80. Casellas, R. et al. Ku80 is required for immunoglobulin isotype switching. EMBO J. 17, 2404-2411 (1998).
81. Manis, J. P. et al. Ku70 is required for late B-cell development and immunoglobulin heavy-chain class switching. J. Exp. Med. 187, 2081-2089 (1998).
82. Kenter, A. & Wuerffel, R. Immunoglobulin switch recombination may occur by a DNA end-joining mechanism. Ann. NY Acad. Sci. 870, 206-217 (1999).
83. Manis, J. P., Dudley, D., Kaylor, L. & Alt, F. W. IgH class-switch recombination to IgG1 in DNA-PKcs-deficient B cells. Immunity 16, 607-617 (2002).
84. Schrader, C. E., Edelmann, W., Kucherlapati, R. & Stavnezer, J. Reduced isotype switching in splenic B cells from mice deficient in mismatch repair enzymes. J. Exp. Med. 190, 323-330 (1999).
85. Ehrenstein, M. R. & Neuberger, M. S. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J. 18, 3484-3490 (1999). This paper shows that B cells from mice that are deficient for Msh2 have an ∼tenfold decrease in CSR activity and have switch junctions that occur most frequently in RGYW hotspot motifs, which indicates that MMR might have a similar function in both SHM and CSR.
86. Ehrenstein, M. R., Rada, C., Jones, A. M., Milstein, C. & Neuberger, M. S. Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class-switch recombination. Proc. Natl Acad. Sci. USA 98, 14553-14558 (2001).
87. Kinoshita, K. & Honjo, T. Linking class-switch recombination with somatic hypermutation. Nature Rev. Mol. Cell. Biol. 2, 493-503 (2001).
88. Nagaoka, H., Muramatsu, M., Yamamura, N., Kinoshita, K. & Honjo, T. Activation-induced deaminase (AID)-directed hypermutation in the immunoglobulin Sμ region: implication of AID involvement in a common step of class switch recombination and somatic hypermutation. J. Exp. Med. 195, 529-534 (2002).
89. Muramatsu, M. et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal-center B cells. J. Biol. Chem 274, 18470-18476 (1999). AID is first reported in this study. AID was cloned by subtraction hybridization from CH12F3-2 B cells that were stimulated to switch to IgA.
90. Madsen, P. et al. Psoriasis-upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1. J. Invest. Dermatol. 113, 162-169 (1999).
91. Davidson, N. O. & Shelness, G. S. Apolipoprotein B: mRNA editing, lipoprotein assembly and presecretory degradation. Annu. Rev. Nutr. 20, 169-193 (2000).
92. Revy, P. et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102, 565-575 (2000).
93. Martin, A. et al. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 415, 802-806 (2002). This report shows that AID is required for SHM by Ramos cells, and that it is sufficient to activate SHM in hybridoma cells, which indicates that AID is the only germinal-centre-specific factor that is required for SHM.
94. Gerber, A. P. & Keller, W. RNA editing by base deamination: more enzymes, more targets, new mysteries. Trends Biochem. Sci. 26, 376-384 (2001).
95. Spencer, J., Dunn, M. & Dunn-Walters, D. K. Characteristic of sequences around individual nucleotide substitutions in IgVH genes suggest different GC and AT mutators. J. Immunol. 162, 6596-6601 (1999).
96. Yamanaka, S., Poksay, K. S., Balestra, M. E., Zeng, G. Q. & Innerarity, T. L. Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity and noncatalytic auxiliary factor(s) of the editing complex are widely distributed J. Biol. Chem. 269, 21725-21734 (1994).
97. Mehta, A., Kinter, M. T., Sherman, N. E. & Driscoll, D. M. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol. Cell. Biol. 20, 1846-1854 (2000).
98. Wang, H., Lawrence, C. W., Li, G. M. & Hays, J. B. Specific binding of human MSH2. MSH6 mismatch-repair protein heterodimers to DNA incorporating thymine- or uracil-containing UV light photoproducts opposite mismatched bases. J. Biol. Chem. 274, 16894-16900 (1999).
99. Rada, C., Jarvis, J. M. & Milstein, C. AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proc. Natl Acad. Sci. USA 99, 7003-7008 (2002).
100. Scharer, O. D. & Jiricny, J. Recent progress in the biology, chemistry and structural biology of DNA glycosylases. Bioessays 23, 270-281 (2001).
101. Pearl, L. H. Structure and function in the uracil-DNA glycosylase superfamily. Mutat. Res. 460, 165-181 (2000).
102. Schatz, D. G. & Baltimore, D. Stable expression of immunoglobulin gene V(D)J recombinase activity by gene transfer into 3T3 fibroblasts. Cell 53, 107-115 (1988).
103. Kolodner, R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev. 10, 1433-1442 (1996).
104. Harfe, B. D. & Jinks-Robertson, S. DNA mismatch repair and genetic instability. Annu. Rev. Genet. 34, 359-399 (2000).
105. Modrich, P. & Lahue, R. Mismatch repair in replication fidelity, genetic recombination and cancer biology. Annu. Rev. Biochem. 65, 101-133 (1996).
106. Storb, U., Shen, H. M., Michael, N. & Kim, N. Somatic hypermutation of immunoglobulin and non-immunoglobulin genes. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356, 13-19 (2001).
107. Kim, N., Bozek, G., Lo, J. C. & Storb, U. Different mismatch repair deficiencies all have the same effects on somatic hypermutation: intact primary mechanism accompanied by secondary modifications. J. Exp. Med. 190, 21-30 (1999).
108. Cascalho, M., Wong, J., Steinberg, C. & Wabl, M. Mismatch repair co-opted by hypermutation. Science 279, 1207-1210 (1998).
109. Bemark, M. et al. Somatic hypermutation in the absence of DNA-dependent protein kinase catalytic subunit (DNA-PK(cs)) or recombination-activating gene (RAG)1 activity. J. Exp. Med. 192, 1509-1514 (2000).
110. Zheng, B., Han, S., Spanopoulou, E. & Kelsoe, G. Immunoglobulin gene hypermutation in germinal centers is independent of the RAG-1 V(D)J recombinase. Immunol. Rev. 162, 133-141 (1998).
111. Jacobs, H. et al. Hypermutation of immunoglobulin genes in memory B cells of DNA repair-deficient mice. J. Exp. Med. 187, 1735-1743 (1998).
112. Essers, J. et al. Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell 89, 195-204 (1997).
113. Bertocci, B. et al. Cutting edge: DNA polymerases μ and λ are dispensable for Ig gene hypermutation. J. Immunol. 168, 3702-3706 (2002).
114. Klein, U., Esposito, G., Baudat, F., Keeney, S. & Jasin, M. Mice deficient for the type II topoisomerase-like DNA transesterase Spo11 show normal immunoglobulin somatic hypermutation and class switching. Eur. J. Immunol. 32, 316-321 (2002).
115. Winter, D. B. & Gearhart, P. J. Altered spectra of hypermutation in DNA repair-deficient mice. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356, 5-11 (2001).
116. Esposito, G. et al. Mice reconstituted with DNA-polymerase-β -deficient fetal liver cells are able to mount a T-cell-dependent immune response and mutate their Ig genes normally. Proc. Natl Acad. Sci. USA 97, 1166-1171 (2000).
117. Petersen-Mahrt, S. K., Harris, R. S. & Neuberger, M. S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418, 99-104 (2002).